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Abstract
Septic shock is a common medical condition with a mortality approaching 50% where early diagnosis and treatment are of particular impor-
tance for patient survival. Novel biomarkers that serve as prompt indicators of sepsis are urgently needed. High-throughput technologies
assessing circulating microRNAs represent an important tool for biomarker identification, but the blood-compartment specificity of these miR-
NAs has not yet been investigated. We characterized miRNA profiles from serum exosomes, total serum and blood cells (leukocytes, erythro-
cytes, platelets) of sepsis patients by next-generation sequencing and RT-qPCR (n = 3 9 22) and established differences in miRNA expression
between blood compartments. In silico analysis was used to identify compartment-specific signalling functions of differentially regulated miR-
NAs in sepsis-relevant pathways. In septic shock, a total of 77 and 103 miRNAs were down- and up-regulated, respectively. A majority of these
regulated miRNAs (14 in serum, 32 in exosomes and 73 in blood cells) had not been previously associated with sepsis. We found a distinctly
compartment-specific regulation of miRNAs between sepsis patients and healthy volunteers. Blood cellular miR-199b-5p was identified as a
potential early indicator for sepsis and septic shock. miR-125b-5p and miR-26b-5p were uniquely regulated in exosomes and serum, respec-
tively, while one miRNA (miR-27b-3p) was present in all three compartments. The expression of sepsis-associated miRNAs is compartment-
specific. Exosome-derived miRNAs contribute significant information regarding sepsis diagnosis and survival prediction and could serve as
newly identified targets for the development of novel sepsis biomarkers.
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Introduction
Sepsis has been described as one of the oldest and most pressing
problems in medicine [1]. Even with treatment in modern intensive
care units (ICUs), mortality rates of patients with septic shock are in
the range between 30% and 44.3% [2] with an even higher in-hospital
mortality of up to 50% [3].
Pathobiological models of sepsis emphasize the important role of
host immunity in disease development. Current theories postulate
that organ injury and death from sepsis are the result of an unabated
activation of innate-immunity-driven inflammation accompanied by a
down-regulation of genes that modulate the adaptive immune
response. On the other hand, there is clear evidence for a prolonged
phase of immunosuppression.
Despite these controversies, there is a consensus that rapid cell-
to-cell communication between the immune system and afflicted
organs plays an important role during the cascade of events leading
from initial contact with an invasive pathogen to the fulminant clinical
syndrome of septic shock.
A growing body of literature suggests that nano-sized extracellular
vesicles, including exosomes, play a critical role in cell-to-cell com-
munication, especially in inflammatory processes and malignancy
[4]. Interestingly, small non-coding microRNAs (miRNAs) are highly
enriched in exosomes and certain miRNAs are over-represented com-
pared to their fraction in the donor cell [5, 6].*Correspondence to: Marlene REITHMAIR MD
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These miRNAs play a crucial role in exosome-mediated pheno-
typic modulation of recipient cells. It is well known that miRNAs are
capable of influencing gene expression by specifically binding to the
30-untranslated region (UTR) of complementary mRNA sequences
and thus repressing their translation. Previous publications were able
to demonstrate that exosomes from platelets under septic insult
induce myocardial dysfunction and apoptosis in endothelial cells, and
may thus contribute to the vascular abnormalities commonly
observed in patients with sepsis [7, 8]. Consequently, cell-to-cell
delivery of miRNAs through circulating exosomes could represent an
important mechanism of long-range signalling during sepsis and
offers promising opportunities for assessing biomarkers in minimally
invasive liquid biopsies.
In this study, we examined serum-derived exosomes from
patients with septic shock and compared their miRNA expression
levels to those from total serum and blood cells (leukocytes, erythro-
cytes, platelets) using comprehensive high-throughput next-genera-
tion sequencing (NGS).
Materials and methods
Patient recruitment and sample collection
In total, 22 critically ill patients with sepsis were included in the study
and matched to 23 healthy volunteers (Table S1). Patients were
recruited from two anaesthesiological ICUs caring for a mixed medical/
surgical patient population of an academic medical centre of the Univer-
sity of Munich and a city hospital of Munich.
Healthy volunteers were recruited from hospital personnel and by
advertisement.
Seven patients with septic shock were initially selected for NGS and
matched to seven age and gender comparable healthy volunteers. RT-
qPCR confirmation of expression levels of selected miRNAs was per-
formed in another 15 patients with varying disease severity and in a
matched control group of equal size.
Blood samples were drawn from healthy subjects via venipuncture
and from patients through intravascular catheters on day 0 and day 4
(if available). Samples to obtain serum were collected into 9 ml serum
tubes (S-Monovette; Sarstedt AG&Co, N€umbrecht, Germany), immedi-
ately centrifuged at 3400 9 g for 10 min. and frozen. Whole blood
samples designated for extraction of cellular miRNAs were collected in
RNA tubes (PAXgene; Qiagen, Hilden, Germany) according to the manu-
facturer’s protocol. Serum aliquots and RNA tubes were stored at
80°C.
Exosome isolation and quality control
3 ml serum was digested with 34 ll thrombin for 5 min. After centrifu-
gation (10,000 9 g, 5 min.), exosomes were isolated from the super-
natant using miRCURYTM Exosome Isolation Kit according to the
manufacturer’s protocol (Exiqon A/S). The presence and purity of exo-
somes were confirmed by transmission electron microscopy (TEM) and
nanoparticle tracking analysis (NTA). Exosomal marker proteins (CD81,
TSG101, syntenin-1) were substantiated by immunoblotting (Fig. 1).
For TEM, exosomes were diluted in PBS and deposited on formvar-
coated copper grids (Plano GmbH, Wetzlar, Germany) for 60 sec. Grids
were negative stained in 2% uranyl acetate (Sigma Aldrich Co., Tauf-
kirchen, Germany) before imaging on a Zeiss EM900 (Carl Zeiss Micro-
scopy GmbH, Munich, Germany) with a wide-angle dual-speed 2K-CCD
camera at 80 kV.
For NTA, exosomes were analysed using a NanoSight LM10 instru-
ment (Malvern Instruments GmbH, Malvern, UK) equipped with a
monochromatic 405 nm laser and a high-sensitivity sCMOS camera.
Exosome preparations were diluted in PBS and recorded by the NTA
software (Malvern Instruments GmbH, Malvern, UK). Five videos of
30 sec. with a frame rate of 25 frames/sec were recorded. Each particle
was subsequently tracked on a frame-by-frame basis by the Finite Track
Length Adjustment algorithm, and the recorded Brownian motion was
used to infer particle sizes by applying the Stokes–Einstein equation.
For Western blot analysis (WB), miRCURYTM precipitates were
washed in PBS and pelleted by ultracentrifugation at 100,000 9 g for
2 hrs (Beckman Coulter Optima LE-80K using a SW60 Ti rotor, k-factor:
167.9, 4°C). The pellets were lysed in ice-cold RIPA buffer with a pro-
tease inhibitor cocktail (Roche Deutschland Holding GmbH, Grenzach-
Wyhlen, Germany). Lysates were sonicated, and then centrifuged at
13,000 9 g for 5 min., and protein concentration in the supernatant
was measured using a BCA assay (Sigma Aldrich) before separation by
SDS-PAGE. Lysates were boiled in reducing sample buffer for 10 min.,
and fractionated using NuPAGE 4–12% Bis-Tris Gels (Invitrogen, Carls-
bad, California, USA). Proteins were transferred to a nitrocellulose
membrane (GE Healthcare Life Sciences, Freiburg, Germany). Primary
antibodies were from antibodies-online.com (rabbit anti-syntenin-1,
ABIN1881779, 1:1000) or OriGene Technologies, Inc., Rockville, Mary-
land, USA (rabbit anti-CD81, TA343281, 1:1000 and rabbit anti-TSG101,
TA343598, 1:500). Secondary antibodies were from Santa Cruz Biotech-
nology, Dallas, Texas, USA (goat anti-rabbit IgG-HRP, sc-2030, 1:5000).
Extraction of extracellular and cellular RNA
After exosome isolation from 3 ml serum, exosomal RNA was extracted
with the miRCURYTM RNA Isolation Kit—Biofluids (Exiqon, Vedbaek,
Denmark) and eluted in 30 ll nuclease-free water.
Serum of 600 ll were extracted with the miRCURYTM RNA Isolation
Kit—Biofluids (Exiqon) according to the manufacturer’s protocol. RNA
was eluted in 30 ll nuclease-free water.
For extraction of blood cell RNA, PAXgene blood tubes were pro-
cessed with the PAXgene blood miRNA kit (Qiagen) according to the
manufacturer’s protocol. Integrity of total blood cell-derived RNA was
assessed with the RNA 6000 Nano assay on the Bioanalyzer 2100 (Agi-
lent Technologies, Inc., Santa Clara, California, USA). Small RNA frac-
tions in cellular and extracellular samples were analysed using the Small
RNA assay and RNA yield for cell-derived RNA was quantified on the
Qubit 2.0 Fluorometer with the RNA HS Assay Kit (Life Technologies,
Carlsbad, California, USA) according to the manufacturer’s protocol.
Calculation of haemolysis scores
Blondal et al. [9] found that in RT-qPCR a delta Cq of miR-23a–miR-
451a >7–8 indicates a high risk for haemolysis bias in the
samples. Haemolysis was assessed for each patient sample by
calculating the Cq ratio of these miRNAs accordingly. All samples
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included in the study showed a delta Cq < 7 and thus a low risk for
haemolysis.
Next-generation sequencing
Blood cell, exosomal and serum RNA from seven patients diagnosed
with septic shock as well as seven healthy volunteers were sequenced
for small RNA.
Blood cell-derived RNA of 100 ng was used as starting material,
while the entire RNA yields from 3 ml, or 600 ll serum were used for
exosomal RNA and serum RNA, respectively. Library preparation was
performed as described in Spornraft et al. [10]. Libraries were subse-
quently subjected to Illumina single-end sequencing by synthesis, using
50 cycles on the HiSeq 2500 (Illumina Inc., San Diego, California, USA).
Sequencing data were processed as described previously [10]. A
log2 fold change ≥|1| and an adjusted p value (Padj) of ≤0.05 were set
as thresholds to identify significantly regulated miRNAs. Only transcripts
with a baseMean ≥50 were included in the analysis. For technical NGS
data, see Figure S1.
Bioinformatic analysis
Ingenuity Pathway Analysis (IPA) (Qiagen) was used for the identifica-
tion of causal networks in our high-throughput miRNA expression data.
In our analyses, we only considered pathways with a negative log P
value >20. Only miRNAs meeting the pre-defined cut-off values
mentioned above were entered into IPA, and only experimentally con-
firmed or highly predicted relationships were considered for the analysis
of miRNA effects.
Significantly regulated miRNAs exclusively present in one of the
compartments (exosomes, serum and blood cells) but not in any of the
others were entered into IPA microRNA Target Filter to identify target
genes of relevance to sepsis. For this purpose, disease filtering was set
to Antimicrobial Response, Inflammatory Response and Infectious Dis-
ease. miRNAs from all three compartments were then included in a
Core Analyses step, which identified pathways and causal networks reg-
ulated within each compartment. In a final step, IPA Comparison Anal-
ysis was used to generate heat maps to visualize and compare the
canonical pathways and disease states of relevance to miRNAs regu-
lated within the three compartments.
RT-qPCR validation
In all, 20 miRNAs covering baseMeans from 69 to 279,000 were inves-
tigated by RT-qPCR in a new cohort of 15 septic patients on day 0
(= day of hospitalization) and day 4, as well as 16 healthy volunteers.
geNorm [11] and NormFinder [12] were used to predict the most stable
miRNAs for each of the three compartments based on the NGS data
set, and six potential reference miRNA candidates were selected. For
RT-qPCR, 10 ng of blood cell-derived RNA was reverse transcribed with
the universal cDNA synthesis kit II according to the manufacturer’s pro-
tocol (Exiqon). Exosomal and serum RNA were normalized to the vol-
ume of starting material (3 ml serum and 600 ll serum, respectively),
Fig. 1 Exosome characterization by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA) and WB. TEM revealed vesicles
with an average size range of about 100–150 nm (A). NTA showed a sharp size distribution with a mean particle diameter of 154.4  40.2 nm for
sepsis patients (black) and 225.2  24.3 nm for volunteers (grey) (B). Exosomes were detected by WB using the exosomal markers CD81, TSG101
and syntenin-1 (C).
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and 2 ll of a 30 ll eluate were subjected to reverse transcription. RT-
qPCR was performed in a 10 ll total reaction volume of ExiLENT
SYBR Green master mix and 1 ll of each miRNA LNATM PCR primer
(Exiqon). PCR reactions were performed on a Rotor-Gene Q (Qiagen) or
CFX384 (Bio-Rad) real-time cycler. Relative quantification was carried
out using the DDCq method [13].
Statistical analysis
Demographic characteristics between volunteers and sepsis patients
were compared using analysis of variance (ANOVA) with post-hoc testing.
For comparison of demographic and clinical parameters between the
NGS group and the RT-qPCR confirmation sample, Student0s t-test was
applied in case of normally distributed data and the Wilcoxon rank-sum
test for non-parametric continuous variables. The Chi-square or Fisher0s
exact test was used for comparison of categorical variables. Data in the
text and in tables are given as mean  SD. To increase clarity in some
of the figures, NGS and RT-qPCR data are expressed as mean  SEM.
Statistical calculations were performed using SPSS (version 24.0, IBM
GmbH, Ehningen, Germany).
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the Medical Faculty
of the University of Munich (protocol #551-14). The study was carried
out according to the World Medical Association Declaration of Helsinki
and all study samples were anonymized during analysis.
Written informed consent for publication of blinded individual
personal data was obtained from each participant or the patient’s legal
representative.
Results
Exosome isolation and characterization
WB analysis revealed the presence of exosome markers CD81,
TSG101 and syntenin-1. Single particle analysis by NTA revealed a
narrow size distribution with mean particle diameters of
154.4  40.2 nm (mode: 110.7  23.5 nm) and 225.2  24.3 nm
(mode: 169.7  21.8 nm) for septic patients and healthy volunteers,
respectively. No significant differences in particle number were
observed between the two groups. TEM revealed a homogeneous
population, no morphological differences were observed in vesicles
from healthy volunteers and sepsis patients (Fig. 1).
Differential gene expression analysis
For each of the three analysed compartments, miRNA reads were
compared between septic shock patients and healthy volunteers.
Compared to healthy volunteers, 77 distinct miRNAs were down-
regulated, whereas 103 distinct miRNAs were up-regulated in septic
shock patients. The majority of regulated miRNAs was found
exclusively in blood cell-derived samples and amounted to 62.14%
for up-regulated and 64.94% for down-regulated miRNAs, respec-
tively. The extracellular compartment accounted for 23.38% of all
down-regulated (exosome: 14.29%; serum: 3.90%; both: 5.19 %)
and 28.16% of all up-regulated (exosome: 15.53%; serum: 3.88%;
both: 8.74%) miRNAs. A small fraction of miRNAs was found to be
simultaneously up- or down-regulated in all three compartments
(2.91% and 3.90%, respectively) (Table S2).
Newly identified sepsis-associated miRNAs
The literature was searched for previously sepsis-associated miRNAs
and compared to significantly regulated miRNAs from this study. For
this purpose, each miRNA was searched for in PubMed in combina-
tion with the terms ‘sepsis’; ‘lipopolysaccharide’ and ‘lps’. miRNAs
with ambiguous literature results were considered as PubMed hits
and thus categorized as previously sepsis-associated. Applying the
mentioned criteria, our NGS dataset provided 32 newly identified sep-
sis-associated miRNAs in exosomes, 14 in serum and 73 in blood
cells (Table S2). Seventeen of these miRNAs were found exclusively
in exosomes, respectively, four and 67 miRNAs in serum or blood
cells. One miRNA, miR-423-5p, was present in all three compart-
ments, showing down-regulation in the sepsis shock cohort.
RT-qPCR validation
Subsequent to normalization with the geometric mean of the reference
miRNAs miR-185-5p and miR-25-3p, differential miRNA expression
between healthy volunteers and patients with sepsis or septic shock
were assessed. For exosome and serum samples, seven out of 12 miR-
NAs (58.3%) selected from NGS results could be validated in RT-qPCR,
while nine out of 14 miRNAs (64.3%) were validated for cellular sam-
ples. Log2 fold changes of validated miRNAs for septic shock patients
in NGS (n = 7) and RT-qPCR (n = 6) were correlated for each com-
partment (Fig. S2). One of the validated miRNAs was present in all
compartments while one, one and eight were unique to exosomes,
serum and blood cells, respectively. Five miRNAs were present in both
extracellular compartments, but not in blood cells (Fig. 2).
Disease detection by miRNAs
RT-qPCR data were screened for miRNAs distinguishing patients with
both sepsis and septic shock from healthy volunteers on the day of
admission to the ICU. One miRNA, cellular miR-199b-5p, also indi-
cated the less severe stage with high confidence (P < 0.001) (Fig. 3).
miRNA expression levels across sepsis stages
In order to assess potential regulations of miRNAs across disease
stages, expression levels from healthy volunteers (n = 16) and patients
at study inclusion (day 0) suffering from sepsis (n = 9) and septic
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shock (n = 6) were compared. Almost linear correlations of expression
level and disease severity were found for 11 different miRNAs in at least
one compartment (three exosomal, one serum, nine cellular) (Fig. 4).
With the exception of cellular miR-150-5p and let-7b-5p, all miRNAs
correlating to disease severity were up-regulated. Two miRNAs showed
correlations in two compartments: miR-27b-3p was simultaneously up-
regulated in exosomes and blood cells from septic patients, while miR-
193a-5p was exclusively up-regulated in extracellular samples. All 11
miRNAs showed significant differences (P < 0.05) in expression levels
between the healthy state and septic shock. Additionally, multiple miR-
NAs in exosomes (miR-21-5p, miR-193a-5p), serum (miR-26b-5p) and
cells (let-7b-5p, miR-27b-3p, miR-143-3p, miR-150-5p, miR-199b-5p,
miR-223-3p) were also able to differentiate (P < 0.05) between healthy
volunteers and septic patients (Fig. S3).
Survival prediction by extracellular miRNAs
RT-qPCR patients were grouped according to outcome (death, n = 4;
survival, n = 11) irrespective of sepsis stage. On the day of admis-
sion to the ICU, three extracellular miRNAs (exosomal miR-30a-5p
and miR-125b-5p, miR-193a-5p in serum) were able to predict sur-
vival with high confidence (P < 0.001) (Fig. 5). Septic shock was
markedly associated with death (75.0% of non-survivors and 27.3%
of survivors were characterized to be in septic shock) with signifi-
cantly different expression levels between disease stages for miR-
193a-5p and miR-125b-5p.
Longitudinal analysis of miRNAs correlating with
disease stage
Expression levels of selected miRNAs on day 0 and day 4 were
assessed by RT-qPCR in a separate experiment on patients with
Fig. 2 Venn diagram of differential miRNA
expression profiles from septic shock
patients validated by RT-qPCR.
Fig. 3 Sepsis detection by miRNAs: Only cellular miR-199b-5p detected
both sepsis and septic shock with high confidence (n = 6).
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Fig. 4 Relationship between miRNA expression level and disease severity. Eleven miRNAs in at least one compartment display stringent correlation
of normalized Cq values and disease severity in septic patients upon admission to the ICU.
Fig. 5 Survival prediction by miRNAs. Exosomal miR-30a-5p and miR-125b-5p and serum miR-193a-5p predict survival of septic patients with high
confidence.
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sepsis (n = 3) and septic shock (n = 5). Some miRNAs showed a
normalization of expression levels on day 4 (miR-100-5p exosomes,
miR-26b-5p serum, miR-143-3p cells), while exosomal miR-199b-5p
was found to become more up-regulated compared to healthy volun-
teers (n = 16) (Fig. 6).
In silico analyses of differentially expressed
miRNAs
Top canonical pathways identified by the target disease-driven
approach mentioned above were Pathogen Influenced Signalling, Cellu-
lar and Humeral Immune Response including Cytokine Signalling, Cellu-
lar Stress Response and Injury and Cardiovascular Signalling (Fig. S4).
Discussion
There are a number of earlier studies that have investigated miRNAs
in the context of sepsis. However, only two studies took a genome-
wide approach for assessing the complete miRNA expression profile
in human patients with sepsis in comparison with non-septic controls
by means of NGS [14, 15]. Another study by Vasilescu et al. [16] pro-
filed miRNAs derived from peripheral blood leukocytes by microarray
analysis and validated the most dysregulated miRNA in their sepsis
cohort, miR-150, in plasma samples from septic patients. Although
their clinical study used a less sensitive approach (microarray instead
of NGS), it is the only one investigating at least one miRNA in both
cellular and extracellular blood compartments in human sepsis
patients. In light of the scarcity of miRNA profiling studies in patients
with this disorder, and taking into consideration the limited possibility
of inter-study comparison due to different compartments, it is essen-
tial to comprehensively profile the blood miRNA signature of critically
ill patients based on all compartments.
Comprehensive small RNA-Seq of blood compartments in septic
individuals, performed in this study, revealed compartment-specific
differences in miRNA profiles. While exosomes and serum were
found to share a significant number of miRNAs, there was very lim-
ited overlap in the miRNA profiles of cellular and extracellular sam-
ples. Individual sampling compartments in blood thus differ not only
in RNA quantity, but also display qualitatively distinct profiles of
bioactive nucleic acids. Particularly, exosomes, released by various
cell populations in the body and thus present in the extracellular blood
fraction, play a major role as miRNA carriers and mediators of inter-
cellular communication [17–19]. Considered an enriched sampling
fraction, the exosomal miRNA profile may serve as an excellent
source of diagnostic biomarkers for identifying sepsis patients early
on, discriminating different sepsis stages or even predicting the
course of the disease. In this context, it is worth mentioning that, to
our knowledge, no clinical study characterizing miRNAs derived from
exosomes as a miRNA-relevant compartment in blood has been car-
ried out in sepsis patients before.
Fig. 6 Significantly different miRNA
expression levels between days 0 and 4.
Samples on day 4 were available from
eight of the patients with sepsis or septic
shock previously used in RT-qPCR
expression analysis at day 0. Grey bars
indicate notable changes in expression
within a group of patients. Tested miRNAs
were exosomal miR21-5p, miR27b-3p,
miR100-5p, miR193a-5p, miR199b-5p,
serum miR26b-5p and miR193a-5p, as
well as blood cellular miR27b-3p,
miR143-3p, miR150-5p, miR199b-5p,
miR223-3p and let-7b-5p.
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When profiling miRNAs differentially regulated in sepsis patients on
the day of admission to the ICU by RT-qPCR, only one blood cell-
derived miRNA (miR-199b-5p) distinguished both sepsis and septic
shock from healthy volunteers. Conversely, the miRNAs significantly
associated with survival (miR-30a-5p, miR-125b-5p, miR-193a-5p)
were found to be extracellular. Due to this non-uniform distribution of
miRNA information across sample types, it seems prudent to choose
the appropriate blood compartment for the respective question at hand.
In our data, tracking miRNAs in patients upon admission to the
ICU and 96 hrs afterwards revealed varying courses of regulation
which were, again, compartment specific. While expression of some
up-/down-regulated miRNAs normalized over time, others were found
to deviate even further from healthy volunteers. This might be due to
heterogeneous patient responses to clinical care, differences in type
of treatment and medication received or a combination thereof. Serial
measurements of compartment-specific miRNAs might therefore also
hold value for sepsis management.
As a conclusion, this study presents the first comprehensive profil-
ing of cellular and extracellular miRNAs in sepsis patients. We found a
distinctly compartment-specific regulation of miRNAs between sepsis
patients and healthy volunteers. NGS-based profiling allowed the identi-
fication of sepsis patients as opposed to healthy volunteers, prognosis
of patient survival and elucidation of miRNA disease functions. Addi-
tionally, we detected multiple compartment-specific, highly regulated
miRNAs that had not previously been associated with sepsis. Most
importantly, our data demonstrate the benefit of including exosomal
miRNAs in disease assessment protocols. The practicality and applica-
bility of sampling miRNAs in liquid biopsies will enhance biomarker
research and eventually the clinical management of sepsis.
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